BioCurate’s Mission
BioCurate’s mission is to identify promising biomedical research discoveries and advance their translation into high-quality pre-clinical candidates for novel human therapeutics. BioCurate was jointly formed by the University of Melbourne and Monash University, with support from the Victorian State Government. BioCurate is operationally independent, with a team of experts who bring decades of scientific and commercial expertise, enabling BioCurate to recognise and realise real-world potential and provides a critical bridge between academia and industry within the biotechnology sector to accelerate the development of new therapies. BioCurate leverages an extensive global network of partners and collaborators to deliver the effective commercial pathways for Australian innovation.
Founded in collaboration between Monash University, the University of Melbourne, and the Victorian State Government in 2016, BioCurate is a ‘venture catalyst’ on a mission to translate therapeutic opportunities into commercially and clinically impactful medicines. It does this, by working with academics to plan and fund the transformation of excellent medical research outcomes into therapeutic candidates which, through partnering, can be taken on the path to market. BioCurate helps bridge the well-known gap between high quality medical discoveries and investable therapeutic assets, bringing not just funds but a wealth of expertise and networks to inform the drug development pathway. Operating independently, we concentrate on the early, yet crucial, stages of therapeutic drug development to facilitate early decision-making and surmount common obstacles to success.
As a venture catalyst, BioCurate invests expertise, hands on project management and financial resources (from $250K to $multimillion). In terms of expertise, the BioCurate team boasts a cumulative experience of over 150 years in the biotechnology and pharmaceutical industries. Leveraging this extensive expertise, the team is proficient in advancing early-stage drug discoveries across various therapeutic modalities and diseases. We adhere to industry best practices, bringing rigour to the commercialisation process to ensure that research projects address unmet clinical needs, possess competitive intellectual property, and are supported by robust scientific data.
BioCurate is cognisant that the interplay between translation and collaboration is the cornerstone for driving advancements that bridge the realms of academia and industry. Academic institutions contribute foundational research, while industry partners leverage their resources and market insights, leading to a symbiotic relationship that accelerates the development and commercialisation of groundbreaking discoveries. Functioning as a vital link between academia and industry, BioCurate is deeply committed to cultivating local capacity and skills. Education, mentoring, and establishing long-term relationships with motivated academic scientists are integral to our mission. Combined with BioCurate’s dedication to commercialising potential therapeutic candidates, these efforts contribute to building a more robust innovation industry in Australia, poised to make a global impact.
BioCurate brings benefit to our community by helping to advance Australian research and innovation globally.
Return to About
BioCurate is the much-needed ‘catalyst’ to generate impact from biomedical research. This impact will be profound and far-reaching – transforming people’s lives, generating commercial returns and driving the innovation economy.
